Suppr
超能文献

Is adjuvant chemotherapy useful for women with luminal a breast cancer?

作者信息

Coates Alan S, Colleoni Marco, Goldhirsch Aron

机构信息

International Breast Cancer Study Group and University of Sydney, Sydney, New South Wales, Australia.

出版信息

J Clin Oncol. 2012 Apr 20;30(12):1260-3. doi: 10.1200/JCO.2011.37.7879. Epub 2012 Feb 21.

DOI:10.1200/JCO.2011.37.7879

PMID:22355052

Abstract

摘要

相似文献

Is adjuvant chemotherapy useful for women with luminal a breast cancer?

J Clin Oncol. 2012 Apr 20;30(12):1260-3. doi: 10.1200/JCO.2011.37.7879. Epub 2012 Feb 21.

Targeting adjuvant chemotherapy: a good idea that needs to be proven!

J Clin Oncol. 2012 Apr 20;30(12):1264-7. doi: 10.1200/JCO.2011.38.4529. Epub 2012 Feb 21.

Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.

Eur J Surg Oncol. 2011 Oct;37(10):876-82. doi: 10.1016/j.ejso.2011.07.001. Epub 2011 Aug 6.

[Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].

Magy Onkol. 2007;51(2):127-31. Epub 2007 Jul 29.

The use of aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer.

J Clin Oncol. 2005 Sep 20;23(27):6807-9. doi: 10.1200/JCO.2005.02.3952.

[Effectiveness of adjuvant systemic therapy in organ preserving treatment of pT1-2N0M0 breast cancer].

Vopr Onkol. 1999;45(5):516-9.

To switch or not to switch: should the study of tamoxifen and raloxifene (STAR) trial alter our decision?

Taiwan J Obstet Gynecol. 2008 Sep;47(3):372-4. doi: 10.1016/S1028-4559(08)60149-7.

Early response to neo-adjuvant chemotherapy in carcinoma of the breast predicts both successful breast-conserving surgery and decreased risk of ipsilateral breast tumor recurrence.

Breast J. 2010 Jan-Feb;16(1):9-13. doi: 10.1111/j.1524-4741.2009.00864.x. Epub 2009 Nov 19.

Limited surgery and tamoxifen in the treatment of elderly breast cancer patients.

World J Surg. 2003 Feb;27(2):125-9. doi: 10.1007/s00268-002-6530-2.

Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer.

Cancer Treat Rev. 2008 Dec;34(8):701-9. doi: 10.1016/j.ctrv.2008.04.002. Epub 2008 Oct 14.

引用本文的文献

Impact of the Prosigna assay on neoadjuvant treatment decision-making in patients with early-stage HR-positive/HER2-negative breast cancer: a single-center prospective observational study.

ESMO Open. 2025 Jul 25;10(8):105521. doi: 10.1016/j.esmoop.2025.105521.

The Effect of Blood Selenium Level on the pCR Rate in Breast Cancer Patient Receiving Neoadjuvant Chemotherapy.

Cancers (Basel). 2025 Feb 28;17(5):839. doi: 10.3390/cancers17050839.

Invasive papillary carcinoma of the breast: A case report.

Oncol Lett. 2024 May 2;28(1):300. doi: 10.3892/ol.2024.14433. eCollection 2024 Jul.

Autocrine phosphatase PDP2 inhibits ferroptosis by dephosphorylating ACSL4 in the Luminal A Breast Cancer.

PLoS One. 2024 Mar 11;19(3):e0299571. doi: 10.1371/journal.pone.0299571. eCollection 2024.

Dendritic Cell Subpopulations Are Associated with Prognostic Characteristics of Breast Cancer after Neoadjuvant Chemotherapy-An Observational Study.

Int J Mol Sci. 2023 Oct 31;24(21):15817. doi: 10.3390/ijms242115817.

Evaluation of the efficacy of chemotherapy for tubular carcinoma of the breast: A Surveillance, Epidemiology, and End Results cohort study.

Cancer Med. 2023 May;12(9):10326-10339. doi: 10.1002/cam4.5763. Epub 2023 Mar 6.

Prognoses of Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy before Surgery: A Retrospective Analysis.

Cancers (Basel). 2023 Feb 10;15(4):1157. doi: 10.3390/cancers15041157.

Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.

World J Surg Oncol. 2022 Sep 29;20(1):326. doi: 10.1186/s12957-022-02787-9.

Luminal A Breast Cancer: How Feasible is Omitting Axillary Dissection Without Neoadjuvant Therapy.

Breast J. 2022 Jul 30;2022:8284814. doi: 10.1155/2022/8284814. eCollection 2022.

Effect of radiotherapy sequence on long-term outcome in patients with node-positive breast cancer: a retrospective study.

Sci Rep. 2022 Jun 24;12(1):10729. doi: 10.1038/s41598-022-14873-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Is adjuvant chemotherapy useful for women with luminal a breast cancer?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译